ACON Shariah Compliance

Screening Methodology: AAOIFI

lock image
LOCKED

Analyst's Ratings for Aclarion Inc (ACON)

Based on 7 analysts giving stock ratings to Aclarion Inc in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
29
Buy
57
Hold
14
Sell
0
Strong Sell
0
Aclarion Inc

Aclarion Inc. Stock Analysis ACON

United States Health Care Nano Cap Report:
Aclarion Inc is a US-based company operating in Health Care Technology industry. The company is headquartered in Broomfield, Colorado and currently employs 6 full-time employees. The company went IPO on 2022-04-22. Aclarion, Inc. is a healthcare technology company. The firm leverages magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. The firm has developed a software application called NOCISCAN. The product uses the existing MRS capabilities of many commercially available scanners to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The software post-processes the MRS exam data and detects the presence of chemical biomarkers that Aclarion, in conjunction with spine researchers at University of California San Francisco (UCSF), have demonstrated to be associated with degenerative pain and structural integrity of the lumbar discs. After processing the MRS exam data, the Company sends the ordering clinician a report that details how to interpret the results of the MRS exam. The platform used to conduct a NOCISCAN involves a diagnostic report called a Nocigram that identifies discs as painful or not.
Read More

Aclarion Inc (ACON) Chart

Aclarion Inc (ACON) vs S&P 500 Comparative Returns

Analysis of Aclarion Inc (ACON) stock performance compared to the broader market (S&P 500) across multiple timeframes.

YTD Performance
  • Aclarion Inc (ACON) 4775%
  • S&P 500 8.2%
Aclarion Inc Outperformed S&P 500 by 4766.80%
1Y Performance
  • Aclarion Inc (ACON) 2787.7%
  • S&P 500 17.63%
Aclarion Inc Outperformed S&P 500 by 2770.07%
3Y Performance
  • Aclarion Inc (ACON) -55.51%
  • S&P 500 54.54%
Aclarion Inc Underperformed S&P 500 by 110.05%
5Y Performance
  • Aclarion Inc (ACON) %
  • S&P 500 94.73%
Aclarion Inc Underperformed S&P 500 by N/A%

Key Statistics of Aclarion Inc (ACON)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$7.00$7.55

Today's Open

$7.00

Volume

24.06K

P/E Ratio (TTM)

-

52 Week Range

$6.20$3,499.47

Market Cap

4.33M

Avg. Volume

12.31K

Dividend Yield

-

Financial Metrics & Statements of Aclarion Inc (ACON)

  • Per Share Data
  • Ratios
  • Statements
Currency: USD20202021202220232024
Revenue per Share (TTM)
0.01 0.12 0.12 0.09 -
EBIT per Share (TTM)
-0.57 -6.04 -11.33 -5.9 -
EPS Forward
- - -18.52 -8.82 -7439.29
  • Annual Icon Annual
  • Quarterly Icon Quarterly
Currency: USD20202021202220232024
Net Margin
-95.38 -82.09 -117.03 -65.14 -152.95
Quick Ratio
0 0.06 2.18 0.37 0.56
Current Ratio
0.01 0.1 2.47 0.4 0.71
Price to Book
0 0 2.04 0 1.55
Gross Margin
-0.36 -0.15 -0.08 0 -0.85
Return on Assets
-3.59 -2.62 -2.43 -2 -3.3
Return on Invested Capital
0 0 -3.18 0 -7.21
Total Debt to Total Asset
1.84 1.06 0 0.46 0
Total Debt to Total Capital
0 0 0 2.83 0
Operating Margin
-92.13 -42.78 -92.08 -64.67 -148.57

FAQ's for Aclarion Inc (ACON)

Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.